These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


462 related items for PubMed ID: 23873474

  • 1. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
    Chaowu Y, Shihua Z, Jian L, Li L, Wei F.
    Circ Heart Fail; 2013 Sep 01; 6(5):1013-20. PubMed ID: 23873474
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS.
    Circulation; 2014 Aug 05; 130(6):484-95. PubMed ID: 25092278
    [Abstract] [Full Text] [Related]

  • 3. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P, Klimeczek P, Vliegenthart R, Pasowicz M, Miszalski-Jamka T, Oudkerk M, Podolec P, Dubiel JS, Tracz W.
    Kardiol Pol; 2009 Aug 05; 67(8A):964-9. PubMed ID: 19784900
    [Abstract] [Full Text] [Related]

  • 4. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS.
    Circ Cardiovasc Imaging; 2012 Jan 05; 5(1):78-85. PubMed ID: 22135401
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.
    Rev Esp Cardiol; 2007 Jan 05; 60(1):15-23. PubMed ID: 17288951
    [Abstract] [Full Text] [Related]

  • 6. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.
    Circ Heart Fail; 2010 Jan 05; 3(1):51-8. PubMed ID: 19850699
    [Abstract] [Full Text] [Related]

  • 7. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
    Spinner JA, Noel CV, Denfield SW, Krishnamurthy R, Jeewa A, Dreyer WJ, Maskatia SA.
    Am J Cardiol; 2016 Apr 15; 117(8):1342-8. PubMed ID: 26892450
    [Abstract] [Full Text] [Related]

  • 8. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M.
    Circ Cardiovasc Imaging; 2013 Sep 15; 6(5):790-9. PubMed ID: 23934992
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A, Kanzaki H, Noguchi T, Morita Y, Sugano Y, Ohara T, Hasegawa T, Hashimura H, Ishibashi-Ueda H, Kitakaze M, Yasuda S, Ogawa H, Anzai T.
    Heart Vessels; 2016 May 15; 31(5):758-70. PubMed ID: 25820658
    [Abstract] [Full Text] [Related]

  • 10. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R, Schulz-Menger J.
    J Am Coll Cardiol; 2009 Jan 20; 53(3):284-91. PubMed ID: 19147047
    [Abstract] [Full Text] [Related]

  • 11. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW, Kim HK.
    Heart; 2015 Jun 20; 101(11):870-6. PubMed ID: 25897040
    [Abstract] [Full Text] [Related]

  • 12. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO.
    Circ Cardiovasc Imaging; 2015 Dec 20; 8(12):. PubMed ID: 26659373
    [Abstract] [Full Text] [Related]

  • 13. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M, Satoh H, Shiraki K, Saotome M, Urushida T, Katoh H, Takehara Y, Sakahara H, Ohtani H, Wakabayashi Y, Ukigai H, Tawarahara K, Hayashi H.
    Magn Reson Imaging; 2014 Feb 20; 32(2):118-24. PubMed ID: 24315973
    [Abstract] [Full Text] [Related]

  • 14. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
    Windram JD, Benson LN, Dragelescu A, Yoo SJ, Mertens L, Wong D, Grosse-Wortmann L.
    Congenit Heart Dis; 2015 Feb 20; 10(6):E258-67. PubMed ID: 26193909
    [Abstract] [Full Text] [Related]

  • 15. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS.
    J Am Coll Cardiol; 2013 Jul 30; 62(5):449-57. PubMed ID: 23643593
    [Abstract] [Full Text] [Related]

  • 16. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG.
    Circ Cardiovasc Imaging; 2014 Jan 30; 7(1):11-9. PubMed ID: 24275954
    [Abstract] [Full Text] [Related]

  • 17. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
    Alter P, Rupp H, Adams P, Stoll F, Figiel JH, Klose KJ, Rominger MB, Maisch B.
    Eur J Heart Fail; 2011 Sep 30; 13(9):937-44. PubMed ID: 21803756
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
    Axelsson Raja A, Farhad H, Valente AM, Couce JP, Jefferies JL, Bundgaard H, Zahka K, Lever H, Murphy AM, Ashley E, Day SM, Sherrid MV, Shi L, Bluemke DA, Canter CE, Colan SD, Ho CY.
    Circulation; 2018 Aug 21; 138(8):782-792. PubMed ID: 29622585
    [Abstract] [Full Text] [Related]

  • 19. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G, Muser D, Gianfagna P, Morocutti G, Proclemer A.
    Int J Cardiovasc Imaging; 2015 Dec 21; 31(8):1603-10. PubMed ID: 26210792
    [Abstract] [Full Text] [Related]

  • 20. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A, Hindieh W, Spears DA, Adler A, Rakowski H, Chan RH.
    J Cardiovasc Electrophysiol; 2019 May 21; 30(5):651-657. PubMed ID: 30680853
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.